These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7708804

  • 1. Gas chromatography/negative ion chemical ionization triple quadrupole mass spectrometric determination and pharmacokinetics of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostan oic acid in plasma.
    Schweer H, Cawello W, Seyberth HW.
    Prostaglandins Leukot Essent Fatty Acids; 1994 Dec; 51(6):401-5. PubMed ID: 7708804
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects.
    Cawello W, Schweer H, Müller R, Bonn R, Seyberth HW.
    Eur J Clin Pharmacol; 1994 Dec; 46(3):275-7. PubMed ID: 8070511
    [Abstract] [Full Text] [Related]

  • 4. Determination of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostan oic acid and 9 alpha,11 alpha-dihydroxy-15-oxo-2,3,4,5,20-pentanor-19-carboxyprostanoi c acid by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry.
    Schweer H, Meese CO, Seyberth HW.
    Anal Biochem; 1990 Aug 15; 189(1):54-8. PubMed ID: 2278391
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry.
    Schweer H, Watzer B, Seyberth HW.
    J Chromatogr; 1994 Feb 11; 652(2):221-7. PubMed ID: 8006107
    [Abstract] [Full Text] [Related]

  • 7. Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Peskar BA, Hesse WH, Rogatti W, Diehm C, Rudofsky G, Schweer H, Seyberth HW.
    Prostaglandins; 1991 Mar 11; 41(3):225-8. PubMed ID: 1852896
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Simultaneous determination of prostaglandin E1, prostaglandin E0 and 15-keto-prostaglandin E0 in human plasma by gas chromatography/negative-ion chemical-ionization tandem mass spectrometry.
    Hammes W, Büchsler U, Kinder P, Bökens H.
    J Chromatogr A; 1999 Jun 25; 847(1-2):187-202. PubMed ID: 10431360
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK, Goodman RP, Fitzgerald GA, Oates JA, Branch RA.
    J Pharmacol Exp Ther; 1982 Apr 25; 221(1):183-7. PubMed ID: 7038095
    [Abstract] [Full Text] [Related]

  • 12. Disposition of 3H-enisoprost, a gastric antisecretory prostaglandin, in healthy humans.
    Allan LM, Hawkins AJ, Vose CW, Firth J, Brownsill RD, Steiner JA.
    Xenobiotica; 1987 Oct 25; 17(10):1233-46. PubMed ID: 3424870
    [Abstract] [Full Text] [Related]

  • 13. Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome.
    Cox JW, Andreadis NA, Bone RC, Maunder RJ, Pullen RH, Ursprung JJ, Vassar MJ.
    Am Rev Respir Dis; 1988 Jan 25; 137(1):5-12. PubMed ID: 3337471
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH, Rudofsky G, Peskar BA.
    Wien Klin Wochenschr; 1991 Jan 25; 103(18):554-7. PubMed ID: 1750222
    [Abstract] [Full Text] [Related]

  • 16. Quantitative analysis of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostanoic acid, the major urinary metabolite of E prostaglandins in man.
    Ferretti A, Flanagan VP, Roman JM.
    Anal Biochem; 1983 Feb 01; 128(2):351-8. PubMed ID: 6846812
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. On the metabolism of prostaglandin E1 administered intravenously to human volunteers.
    Peskar BA, Cawello W, Rogatti W, Rudofsky G.
    J Physiol Pharmacol; 1991 Sep 01; 42(3):327-31. PubMed ID: 1793892
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis.
    Leonhardt A, Krauss M, Gieler U, Schweer H, Happle R, Seyberth HW.
    Br J Dermatol; 1997 Mar 01; 136(3):337-40. PubMed ID: 9115911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.